The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

“This is what happens when everything merges and you only have one option.”

Researchers remark that their findings “raise concerns about competition and call for closer scrutiny by the Federal Trade Commission, state regulators and policy makers.”

A joint announcement from the DOJ, FTC and HHS asks for providers, patients or other industry experts to share their experiences with private equity transactions, including those not typically subject to antitrust review by law.

A February analysis showed more than 11 million Americans owe healthcare providers between $1,001 and $10,000. Another 3 million owe more than $10K.

Medicare Advantage covers a disproportionate share of disadvantaged senior citizens compared with traditional fee-for-service Medicare, yet the former bests the latter on some key outcomes metrics.

Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift.